Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Moderna, Inc. (NASDAQ:MRNA) is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at ...
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
A social media post claims that Moderna’s CEO confessed to creating a COVID vaccine before the pandemic. After fact checking, ...
Moderna has been ordered to pay almost £44,000 after 12-year-olds were encouraged to join Covid vaccine trials with the ...
Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, ...
Idaho Statesman on MSN8d
Idaho Republican pushes ban of mRNA vaccines against COVID, gene therapy productsThe bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.
We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before the opening bell. In the last reported quarter, MRNA’s earnings beat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results